Macular Degeneration Treatment Market Report 2026
Download Free Sample Buy Now
Macular Degeneration Treatment Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Macular Degeneration Treatment Market Report 2026

Global Outlook – By Stage of Disease (Early-Stage AMD, Intermediate AMD, Late-Stage AMD), By Route of Administration (Oral, Injectable, Other Routes of Administration), By End User (Ambulatory Surgical Centers, Ophthalmic Clinics, Hospitals) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Macular Degeneration Treatment Market Overview

• Macular Degeneration Treatment market size has reached to $12.38 billion in 2025

• Expected to grow to $20.74 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%

• Growth Driver: Growing Retinal Disorder Incidence Propels Macular Degeneration Treatment Market

• Market Trend: Biosimilar Advancements in Age-Related Macular Degeneration (AMD) Treatment: FDA Approvals for Yesafili and Opuviz

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Macular Degeneration Treatment Market?

Macula refers to the central portion of the retina, a light-sensitive layer of tissue at the back of the eye. The macula is responsible for central vision. Degeneration of the macula, which affects the central part of the retina (the macula) and results in distortion or loss of central vision, occurs most commonly after the age of 60 and is referred to as age-related macular generation (AMD). The macular degeneration treatment is used to treat macular degeneration eye disease and slow the disease and prevent severe loss of vision.

The main disease stages in the macular degeneration treatment market are early-stage AMD, intermediate AMD, and late-stage AMD. In early-stage AMD, the macula changes, with medium-sized drusen deposits and no pigment changes, but this does not impact vision. Intermediate AMD is when vision may get blurry or wavy with large drusen or pigment changes. In late-stage AMD, the central vision fails completely, causing vision loss. The different types of macular degeneration treatments include wet macular degeneration and dry macular degeneration. The different routes of administration of macular degeneration treatment include oral, injectable, and others used by different end-users such as ambulatory surgical centers, ophthalmic clinics, and hospitals.

Macular Degeneration Treatment Market Global Report 2026 Market Report bar graph

What Is The Macular Degeneration Treatment Market Size and Share 2026?

The macular degeneration treatment market size has grown rapidly in recent years. It will grow from $12.38 billion in 2025 to $13.81 billion in 2026 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to aging global population, increased prevalence of age-related macular degeneration, clinical success of anti-vegf injections, improved ophthalmic diagnostic capabilities, growing access to specialized eye care services.

What Is The Macular Degeneration Treatment Market Growth Forecast?

The macular degeneration treatment market size is expected to see rapid growth in the next few years. It will grow to $20.74 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to rising elderly population worldwide, increasing investment in advanced retinal therapies, growing focus on early-stage amd management, expanding adoption of gene and regenerative therapies, higher healthcare spending on vision care. Major trends in the forecast period include rising focus on early diagnosis and disease progression control, growing adoption of anti-vegf therapies, increasing demand for long-term vision preservation treatments, expansion of minimally invasive treatment options, rising awareness of age-related eye disorders.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Macular Degeneration Treatment Market Segmentation

1) By Stage of Disease: Early-Stage AMD, Intermediate AMD, Late-Stage AMD

2) By Route of Administration: Oral, Injectable, Other Routes of Administration

3) By End User: Ambulatory Surgical Centers, Ophthalmic Clinics, Hospitals

Subsegments:

1) By Early-Stage AMD: Nutritional Supplements, Lifestyle Modification Treatments

2) By Intermediate AMD: Regular Disease Monitoring and Imaging Surveillance, Risk-Factor Management and Lifestyle Modification

3) By Late-Stage AMD: Surgical Treatments, Advanced Anti-VEGF Therapies, Gene Therapy Options

What Is The Driver Of The Macular Degeneration Treatment Market?

The increasing burden of retinal disorders is expected to propel the growth of the macular degeneration treatment market. Retinal disorders affect the vital tissue and affect the way individuals process visual information, leading to distorted or absent vision. For instance, according to the American Academy of Ophthalmology, in 2050, an estimated 7.32 million people in the United States will have primary open-angle glaucoma, a general term used to describe a group of eye disorders, with the highest numbers among populations aged 70 to 79 years (32%), women (50%), and Hispanics (50%). The largest demographic group is Hispanic men. Therefore, the increasing burden of retinal disorders is driving the growth of the macular degeneration treatment industry.

Key Players In The Global Macular Degeneration Treatment Market

Major companies operating in the macular degeneration treatment market are F Hoffmann La Roche Ltd, Regeneron Pharmaceuticals Inc, Novartis AG, Bayer AG, Allergan Inc, Bausch Health Companies Inc, Santen Pharmaceutical Co Ltd, Alimera Sciences Inc, Apellis Pharmaceuticals Inc, Iveric Bio Inc, Aerie Pharmaceuticals Inc, Kodiak Sciences Inc, Neurotech Pharmaceuticals Inc, Regenxbio Inc, Adverum Biotechnologies Inc, Applied Genetic Technologies Corp, 4D Molecular Therapeutics Inc, GenSight Biologics SA, Nanoscope Therapeutics Inc, Annexon Inc, Ocular Therapeutix Inc, Graybug Vision Inc

Global Macular Degeneration Treatment Market Trends and Insights

Major companies operating in the macular degeneration treatment market are focused on developing biosimilars for the treatment of age-related macular degeneration (AMD) to increase accessibility to effective therapies. Biosimilars refer to biological medical products that are highly similar to an already approved reference product, with no clinically meaningful differences in terms of safety, purity, or potency. For instance, in May 2024, Biocon Biologics Ltd, an Indian-based company, and Samsung Bioepis Co. Ltd, a South Korea-based company, recevied FDA Approvals for Yesafili and Opuviz, two new biosimilars. Both biosimilars inhibit vascular endothelial growth factor (VEGF), which is responsible for abnormal blood vessel growth in the eye. This action helps prevent vision loss associated with conditions like AMD and diabetic retinopathy. The FDA's approval process included comparative studies showing that Yesafili and Opuviz have no significant differences in efficacy or safety compared to Eylea. These studies involved rigorous assessments of the biosimilars' pharmacokinetics and immunogenicity.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Macular Degeneration Treatment Market?

In July 2023, Harrow Inc., a US-based company, acquired Santen for $8 million. With this acquisition, Harrow aims to expand its portfolio by incorporating Santen's expertise in providing macular degeneration treatment. Santen Pharmaceutical Co., Ltd. is a Japan-based company that offers macular degeneration treatment.

Regional Outlook

North America was the largest region in the macular degeneration treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Macular Degeneration Treatment Market?

The macular degeneration treatment market includes revenues earned by entities by anti-angiogenic drugs, photodynamic therapy, laser therapy and low vision aids. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Macular Degeneration Treatment Market Report 2026?

The macular degeneration treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the macular degeneration treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Macular Degeneration Treatment Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $13.81 billion
Revenue Forecast In 2035 $20.74 billion
Growth Rate CAGR of 11.5% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Stage of Disease, Route of Administration, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled F Hoffmann La Roche Ltd, Regeneron Pharmaceuticals Inc, Novartis AG, Bayer AG, Allergan Inc, Bausch Health Companies Inc, Santen Pharmaceutical Co Ltd, Alimera Sciences Inc, Apellis Pharmaceuticals Inc, Iveric Bio Inc, Aerie Pharmaceuticals Inc, Kodiak Sciences Inc, Neurotech Pharmaceuticals Inc, Regenxbio Inc, Adverum Biotechnologies Inc, Applied Genetic Technologies Corp, 4D Molecular Therapeutics Inc, GenSight Biologics SA, Nanoscope Therapeutics Inc, Annexon Inc, Ocular Therapeutix Inc, Graybug Vision Inc
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Macular Degeneration Treatment Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Macular Degeneration Treatment Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Macular Degeneration Treatment Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Macular Degeneration Treatment Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Focus On Early Diagnosis And Disease Progression Control

4.2.2 Growing Adoption Of Anti-Vegf Therapies

4.2.3 Increasing Demand For Long-Term Vision Preservation Treatments

4.2.4 Expansion Of Minimally Invasive Treatment Options

4.2.5 Rising Awareness Of Age-Related Eye Disorders

5. Macular Degeneration Treatment Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Ophthalmic Clinics

5.3 Ambulatory Surgical Centers

5.4 Specialty Eye Care Centers

5.5 Geriatric Care Facilities

6. Macular Degeneration Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Macular Degeneration Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Macular Degeneration Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Macular Degeneration Treatment Market Size, Comparisons And Growth Rate Analysis

7.3. Global Macular Degeneration Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Macular Degeneration Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Macular Degeneration Treatment Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Macular Degeneration Treatment Market Segmentation

9.1. Global Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Early-Stage AMD, Intermediate AMD, Late-Stage AMD

9.2. Global Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Injectable, Other Routes of Administration

9.3. Global Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Ambulatory Surgical Centers, Ophthalmic Clinics, Hospitals

9.4. Global Macular Degeneration Treatment Market, Sub-Segmentation Of Early-Stage AMD, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Nutritional Supplements, Lifestyle Modification Treatments

9.5. Global Macular Degeneration Treatment Market, Sub-Segmentation Of Intermediate AMD, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Regular Disease Monitoring and Imaging Surveillance, Risk-Factor Management and Lifestyle Modification

9.6. Global Macular Degeneration Treatment Market, Sub-Segmentation Of Late-Stage AMD, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Surgical Treatments, Advanced Anti-VEGF Therapies, Gene Therapy Options

10. Macular Degeneration Treatment Market Regional And Country Analysis

10.1. Global Macular Degeneration Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Macular Degeneration Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Macular Degeneration Treatment Market

11.1. Asia-Pacific Macular Degeneration Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Macular Degeneration Treatment Market

12.1. China Macular Degeneration Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Macular Degeneration Treatment Market

13.1. India Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Macular Degeneration Treatment Market

14.1. Japan Macular Degeneration Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Macular Degeneration Treatment Market

15.1. Australia Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Macular Degeneration Treatment Market

16.1. Indonesia Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Macular Degeneration Treatment Market

17.1. South Korea Macular Degeneration Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Macular Degeneration Treatment Market

18.1. Taiwan Macular Degeneration Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Macular Degeneration Treatment Market

19.1. South East Asia Macular Degeneration Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Macular Degeneration Treatment Market

20.1. Western Europe Macular Degeneration Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Macular Degeneration Treatment Market

21.1. UK Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Macular Degeneration Treatment Market

22.1. Germany Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Macular Degeneration Treatment Market

23.1. France Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Macular Degeneration Treatment Market

24.1. Italy Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Macular Degeneration Treatment Market

25.1. Spain Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Macular Degeneration Treatment Market

26.1. Eastern Europe Macular Degeneration Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Macular Degeneration Treatment Market

27.1. Russia Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Macular Degeneration Treatment Market

28.1. North America Macular Degeneration Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Macular Degeneration Treatment Market

29.1. USA Macular Degeneration Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Macular Degeneration Treatment Market

30.1. Canada Macular Degeneration Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Macular Degeneration Treatment Market

31.1. South America Macular Degeneration Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Macular Degeneration Treatment Market

32.1. Brazil Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Macular Degeneration Treatment Market

33.1. Middle East Macular Degeneration Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Macular Degeneration Treatment Market

34.1. Africa Macular Degeneration Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Segmentation By Route of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Macular Degeneration Treatment Market Regulatory and Investment Landscape

36. Macular Degeneration Treatment Market Competitive Landscape And Company Profiles

36.1. Macular Degeneration Treatment Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Macular Degeneration Treatment Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Macular Degeneration Treatment Market Company Profiles

36.3.1. F Hoffmann La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Regeneron Pharmaceuticals Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Allergan Inc Overview, Products and Services, Strategy and Financial Analysis

37. Macular Degeneration Treatment Market Other Major And Innovative Companies

Bausch Health Companies Inc, Santen Pharmaceutical Co Ltd, Alimera Sciences Inc, Apellis Pharmaceuticals Inc, Iveric Bio Inc, Aerie Pharmaceuticals Inc, Kodiak Sciences Inc, Neurotech Pharmaceuticals Inc, Regenxbio Inc, Adverum Biotechnologies Inc, Applied Genetic Technologies Corp, 4D Molecular Therapeutics Inc, GenSight Biologics SA, Nanoscope Therapeutics Inc, Annexon Inc

38. Global Macular Degeneration Treatment Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Macular Degeneration Treatment Market

40. Macular Degeneration Treatment Market High Potential Countries, Segments and Strategies

40.1 Macular Degeneration Treatment Market In 2030 - Countries Offering Most New Opportunities

40.2 Macular Degeneration Treatment Market In 2030 - Segments Offering Most New Opportunities

40.3 Macular Degeneration Treatment Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Macular Degeneration Treatment Market, Overview Of Key Products - Product Examples
  • Table 2: Global Macular Degeneration Treatment Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Macular Degeneration Treatment Market, Supply Chain Analysis
  • Table 4: Global Macular Degeneration Treatment Market, Major Raw Material Providers
  • Table 5: Global Macular Degeneration Treatment Market, Major Resource Providers
  • Table 6: Global Macular Degeneration Treatment Market, Major Manufacturers (Suppliers)
  • Table 7: Global Macular Degeneration Treatment Market, Major Distributors And Channel Partners
  • Table 8: Global Macular Degeneration Treatment Market, Key Technologies & Future Trends
  • Table 9: Global Macular Degeneration Treatment Market, Major Trends
  • Table 10: Global Macular Degeneration Treatment Market, Major End Users
  • Table 11: Global Macular Degeneration Treatment Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Macular Degeneration Treatment Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Macular Degeneration Treatment Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Macular Degeneration Treatment Market - TAM, US$ Billion, 2025
  • Table 15: Global Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Macular Degeneration Treatment Market, Sub-Segmentation Of Early-Stage AMD, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Macular Degeneration Treatment Market, Sub-Segmentation Of Intermediate AMD, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Macular Degeneration Treatment Market, Sub-Segmentation Of Late-Stage AMD, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Macular Degeneration Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Macular Degeneration Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Global Macular Degeneration Treatment Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 96: Global Macular Degeneration Treatment Market - Company Scoring Matrix
  • Table 97: F Hoffmann La Roche Ltd Financial Performance
  • Table 98: Regeneron Pharmaceuticals Inc Financial Performance
  • Table 99: Novartis AG Financial Performance
  • Table 100: Bayer AG Financial Performance
  • Table 101: Allergan Inc Financial Performance
  • Table 102: Global Macular Degeneration Treatment Market, Competitive Benchmarking (In USD Billions)
  • Table 103: Global Macular Degeneration Treatment Market, Competitive Dashboard
  • Table 104: Global Macular Degeneration Treatment Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 105: Global, Macular Degeneration Treatment Market Size Gain ($ Billion), Segmentation By Stage of Disease, 2025 – 2030
  • Table 106: Global, Macular Degeneration Treatment Market Size Gain ($ Billion), Segmentation By Route of Administration, 2025 – 2030
  • Table 107: Global, Macular Degeneration Treatment Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

    Figure 1: Global Macular Degeneration Treatment Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Macular Degeneration Treatment Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Macular Degeneration Treatment Market, Supply Chain Analysis
  • Figure 4: Global Macular Degeneration Treatment Market, Major Raw Material Providers
  • Figure 5: Global Macular Degeneration Treatment Market, Major Resource Providers
  • Figure 6: Global Macular Degeneration Treatment Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Macular Degeneration Treatment Market, Major Distributors And Channel Partners
  • Figure 8: Global Macular Degeneration Treatment Market, Key Technologies & Future Trends
  • Figure 9: Global Macular Degeneration Treatment Market, Major Trends
  • Figure 10: Global Macular Degeneration Treatment Market, Major End Users
  • Figure 11: Global Macular Degeneration Treatment Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Macular Degeneration Treatment Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Macular Degeneration Treatment Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Macular Degeneration Treatment Market - TAM, US$ Billion, 2025
  • Figure 15: Global Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Macular Degeneration Treatment Market, Sub-Segmentation Of Early-Stage AMD, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Macular Degeneration Treatment Market, Sub-Segmentation Of Intermediate AMD, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Macular Degeneration Treatment Market, Sub-Segmentation Of Late-Stage AMD, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Macular Degeneration Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Macular Degeneration Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Macular Degeneration Treatment Market, Segmentation By Stage of Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Macular Degeneration Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Macular Degeneration Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Global Macular Degeneration Treatment Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 96: Global Macular Degeneration Treatment Market - Company Scoring Matrix
  • Figure 97: F Hoffmann La Roche Ltd Financial Performance
  • Figure 98: Regeneron Pharmaceuticals Inc Financial Performance
  • Figure 99: Novartis AG Financial Performance
  • Figure 100: Bayer AG Financial Performance
  • Figure 101: Allergan Inc Financial Performance
  • Figure 102: Global Macular Degeneration Treatment Market, Competitive Benchmarking (In USD Billions)
  • Figure 103: Global Macular Degeneration Treatment Market, Competitive Dashboard
  • Figure 104: Global Macular Degeneration Treatment Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 105: Global, Macular Degeneration Treatment Market Size Gain ($ Billion), Segmentation By Stage of Disease, 2025 – 2030
  • Figure 106: Global, Macular Degeneration Treatment Market Size Gain ($ Billion), Segmentation By Route of Administration, 2025 – 2030
  • Figure 107: Global, Macular Degeneration Treatment Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Macular Degeneration Treatment Market Report 2026 - Global Outlook – By Stage of Disease (Early-Stage AMD, Intermediate AMD, Late-Stage AMD), By Route of Administration (Oral, Injectable, Other Routes of Administration),...

Macular Edema and Macular Degeneration Market Report 2026 - Global Outlook – By Treatment Type (Drug Therapy, Laser Treatment), By Application (Macular Edema, Diabetic Macular Edema (DME), Cystoid Macular Edema (CME), Ma...

Age-Related Macular Degeneration Market Report 2026 - Global Outlook – By Type (Wet Age-Related Macular Degeneration (AMD), Dry Age-Related Macular Degeneration (AMD)), By Drug (Eylea, Lucentis, Avastin, Other Drugs), By...

Retinal Disorder Treatment Market Report 2026 - Global Outlook – By Type (Macular Degeneration, Diabetic Retinopathy, Other Types), By Dosage Form (Gels, Eye Solutions, Capsules And Tablets, Eye Drops, Ointments), By Dis...

Ocular Inflammation Treatment Market Report 2026 - Global Outlook – By Treatment Type (Immunosuppressant, Antivirals, Corticosteroids, Monoclonal Antibodies, Antifungal, Cycloplegic), By Mode Of Operation (Injectables, O...

Anemia And Other Blood Disorder Drugs Market Report 2026 - Global Outlook – By Type (Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia ), By Route of Administration (Oral, Injecta...

Ocular Hypertension Treatment Market Report 2026 - Global Outlook – By Type (Intraocular Hypertension, Glaucoma), By Route Of Administration (Oral, Parenteral, Other Route Of Administrations), By Distribution Channel (Ho...

Optic Nerve Disorders Treatment Market Report 2026 - Global Outlook – By Treatment Type (Steroidal Therapy, Immunomodulators therapy, Other Treatment Types), By Indication (Glaucoma, Optic Neuritis, Optic Neuropathy, Con...

Frequently Asked Questions

The Macular Degeneration Treatment market was valued at $12.38 billion in 2025, increased to $13.81 billion in 2026, and is projected to reach $20.74 billion by 2030.

The global Macular Degeneration Treatment market is expected to grow at a CAGR of 10.7% from 2026 to 2035 to reach $20.74 billion by 2035.

Some Key Players in the Macular Degeneration Treatment market Include, F Hoffmann La Roche Ltd, Regeneron Pharmaceuticals Inc, Novartis AG, Bayer AG, Allergan Inc, Bausch Health Companies Inc, Santen Pharmaceutical Co Ltd, Alimera Sciences Inc, Apellis Pharmaceuticals Inc, Iveric Bio Inc, Aerie Pharmaceuticals Inc, Kodiak Sciences Inc, Neurotech Pharmaceuticals Inc, Regenxbio Inc, Adverum Biotechnologies Inc, Applied Genetic Technologies Corp, 4D Molecular Therapeutics Inc, GenSight Biologics SA, Nanoscope Therapeutics Inc, Annexon Inc, Ocular Therapeutix Inc, Graybug Vision Inc .

Major trend in this market includes: Biosimilar Advancements in Age-Related Macular Degeneration (AMD) Treatment: FDA Approvals for Yesafili and Opuviz. For further insights on this market. request a sample here

North America was the largest region in the macular degeneration treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the macular degeneration treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us